- Home
- ONC vs CAH Comparison
ONC vs CAH Comparison
Compare ONC & CAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONC
- CAH
- Stock Information
- Founded
- ONC 2010
- CAH 1979
- Country
- ONC Switzerland
- CAH United States
- Employees
- ONC N/A
- CAH N/A
- Industry
- ONC Biotechnology: Pharmaceutical Preparations
- CAH Other Pharmaceuticals
- Sector
- ONC Health Care
- CAH Health Care
- Exchange
- ONC Nasdaq
- CAH Nasdaq
- Market Cap
- ONC 31.5B
- CAH 37.5B
- IPO Year
- ONC N/A
- CAH N/A
- Fundamental
- Price
- ONC $299.01
- CAH $155.98
- Analyst Decision
- ONC Strong Buy
- CAH Buy
- Analyst Count
- ONC 9
- CAH 15
- Target Price
- ONC $332.44
- CAH $154.67
- AVG Volume (30 Days)
- ONC 411.4K
- CAH 1.7M
- Earning Date
- ONC 08-06-2025
- CAH 08-12-2025
- Dividend Yield
- ONC N/A
- CAH 1.31%
- EPS Growth
- ONC N/A
- CAH 155.27
- EPS
- ONC N/A
- CAH 6.38
- Revenue
- ONC $4,175,868,000.00
- CAH $222,286,000,000.00
- Revenue This Year
- ONC $865.19
- CAH N/A
- Revenue Next Year
- ONC $21.12
- CAH $11.62
- P/E Ratio
- ONC N/A
- CAH $24.45
- Revenue Growth
- ONC 51.16
- CAH 0.86
- 52 Week Low
- ONC $155.75
- CAH $96.05
- 52 Week High
- ONC $308.87
- CAH $168.44
- Technical
- Relative Strength Index (RSI)
- ONC N/A
- CAH 40.82
- Support Level
- ONC N/A
- CAH $152.59
- Resistance Level
- ONC N/A
- CAH $158.73
- Average True Range (ATR)
- ONC 0.00
- CAH 2.61
- MACD
- ONC 0.00
- CAH -0.62
- Stochastic Oscillator
- ONC 0.00
- CAH 36.61
About ONC BeiGene Ltd. American Depositary Shares
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeiGene's revenue.
About CAH Cardinal Health Inc.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.